Mono (S) hydroxy fatty acids: Novel ligands for cytosolic actin

Journal of Lipid Research

Volumn 39, Issue 7, 1998, Pages 1476-1482

  Kang, Li Ta ^a   Vanderhoek, Jack Y ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

5 lipoxygenase; Binding; Chemiluminescence; Inhibition

Indexed keywords

ACTIN; HYDROXY FATTY ACID; LIPOXYGENASE;

AMINO ACID SEQUENCE; ARTICLE; CHEMOLUMINESCENCE; ENZYME INHIBITION; LIPID METABOLISM; METABOLIC REGULATION; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; SEQUENCE ANALYSIS;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ACTINS; AMINO ACID SEQUENCE; ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; BIOTINYLATION; CARRIER PROTEINS; CYTOSOL; DINOPROST; FATTY ACID-BINDING PROTEINS; HYDROXYEICOSATETRAENOIC ACIDS; KINETICS; LEUKEMIA, BASOPHILIC, ACUTE; LIGANDS; LINOLEIC ACID; LINOLEIC ACIDS; MOLECULAR SEQUENCE DATA; MYELIN P2 PROTEIN; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; OLEIC ACID; RATS; STEARIC ACIDS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0031823859     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Spector, A. A., J. A. Gordon, and S. A. Moore. 1988. Hydroxyeicosatetraenoic acids (HETEs). Prog. Lipid Res. 27: 271-323.
2. Stenson, W. F., and C. W. Parker. 1980. Monohydroxyeicosatetraenoic acids (HETEs) induce degranulatiun of human neutrophils. J. Immunol. 124: 2100-2104.
3. 3 on melanoma cells. Int. J. Cancer. 49: 774-786.
4. Marom, Z., J. H. Shelhamer, F. Sun, and M. J. Kaliner. 1983. Human airway monohydroxyeicosatetraenoic acid generation and mucus release. J. Clin. Invest. 72: 122-127.
5. Buchanan, M. R., T. A. Haas, M. Lagarde, and M. Guichardant. 1985. 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J. Biol. Chem. 260: 16056-16059.
6. Chang, J., E. Blazek, A. F. Kreft, and A. J. Lewis. 1985. Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETEs). A novel pharmacological mechanism for regulating free fatty acid release. Biochem. Pharmacol. 34: 1571-1575.
7. Vanderhoek, J. Y., R. W. Bryant, and J. M. Bailey. 1980. 15-Hydroxy-5,8,11,13-eicosatetraenoic acid, a potent and selective inhibitor of platelet lipoxygenase. J. Biol. Chem. 255: 5996-5998.
8. Vanderhoek, J. Y., R. W. Bryant, and J. M. Bailey. 1980. Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. J. Biol. Chem. 255: 10064-10066.
9. Kang, L. T., and J. Y. Vanderhoek. 1995. Characterization of specific subcellular 15-hydroxyeicosatelraenoic acid (15-HETE) binding sites on rat basophilic leukemia cells. Biochim. Biophys. Acta. 1256: 297-304.
10. Vanderhoek, J. Y., R. W. Bryant, and J. M. Bailey. 1982. Regulation of leukocyte and platelet lipoxygenases by hydroxyeicosanoids. Biochem. Pharmacol. 31: 3463-3467.
11. Kang, L. T., and J. Y. Vanderhoek. 1997. Synthesis and use of a novel biotinylated probe for the chemiluminescent detection of proteins that bind 15-hydroxyeicosatetraenoic acid. Anal. Biochem. 250: 119-122.
12. Ueyama, H., H. Hamada, N. Battula, and T. Kakunaga. 1984. Structure of a human smooth muscle actin gene (aortic type) with a unique intron site. Mol. Cell. Biol. 4: 1073-1078.
13. Haviv, F., J. D. Ratajczyk, R. W. DeNet, Y. C. Martin, R. D. Dyer, and G. W. Carter. 1987. Structural requirements for the inhibition of 5-lipoxygenase by 15-hydroxy-5,8,11,13-tetraenoic acid analogues. J. Med. Chem. 30: 254-263.
14. Petrich, K., P. Ludwig, H. Kuhn, and T. Schewe. 1996. The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(52, 8Z, 11Z, 13E)-eicosatetraenoic acid: structure-activity relationship and mechanism of action. Biochem. J. 314: 911-916.
15. Xu, L. Z., R. Sanchez, A. Sali, and N. Heintz. 1996. Ligand specificity of brain lipid-binding protein. J. Biol. Chem. 271: 24711-24719.
16. Raza, H., W. L. Chung, and H. Mukhtar. 1991. Specific high-affinity binding of fatty acids to epidermal cytosolic proteins. J. Invest. Dermatol. 97: 323-326.
17. Kane, C. D., N. R. Coe, B. Vanlandingham, P. Krieg, and D. A Bernlohr. 1996. Expression, purification and ligand-binding analysis of recombinant keratinocyte lipid-binding protein (MAL-1), an intracellular lipid-binding found overexpressed in neoplastic skin cells. Biochemistry. 35: 2894-2900.
18. Goldman, D. W., L. A. Gifford, P. M. Young, T. Marotti, M. K. Cheung, and E. J. Goetzl. 1991. Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4. J. Immunol. 146: 2671-2677.
19. Herbertsson, H., and S. Hammarstrom. 1995. Subcellular localization of 12(S)-hydroxy-5,8,10, 14-eicosatetraenoic acid binding sites in Lewis lung carcinoma cells. Biochim. Biophys. Acta. 1244: 191-197.
20. Sozzani, S., D. Zhou, M. Locati, S. Bernasconi, W. Luini, A. Mantovani, and J. T. O'Flaherty. 1996. Stimulating properties of 5-oxoeicosanoids for human monocytes. Synergism with monocyte chemotactic protein-1 and -3. J. Immunol. 157: 4664-4671.
21. Tang, D. T., J. Timar, I. M. Grossi, C. Renaud, V. A. Kimler, C. A. Diglio, J. D. Taylor, and K. V. Honn. 1993. The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Exp. Cell Res. 207: 361-375.